Turk J Med Sci
-
This study aims to determine the validity and reliability of the Turkish version of the Neck OutcOme Score (NOOS). ⋯ It was found that the Turkish version of the NOOS is valid and reliable.
-
The aim of this study was to investigate the importance of preprocedural uric acid (UA) level in predicting fractional flow reserve (FFR) results of intermediate coronary lesions in patients with stable coronary artery disease undergoing coronary angiography. ⋯ Elevated UA levels are associated with hemodynamically significant coronary lesions measured with FFR. Uric acid may be used as a predictor of hemodynamically compromised coronary lesions before FFR procedures.
-
The aim of this study is to assess the validity and reliability of Turkish translation of the Physical Activity Scale for Individuals with Physical Disabilities (PASIPD) in a disabled Turkish population. ⋯ The Turkish version of the PASIPD survey is valid and reliable for developmentally and physically disabled Turkish individuals and professionals can use it to assess physical activity level.
-
This study aimed to assess the correlations of actual epidural depth (ND) and ultrasound estimated epidural depth in the paramedian sagittal oblique plane (ED/PSO) and transverse median plane (ED/TM) with the abdominal girth (AG), body mass index (BMI), and weight of patients. ⋯ AG, weight, and BMI have strong correlations with ND.
-
Cisplatin is a highly effective chemotherapeutic agent used in the treatment of solid organ cancers. Besides its chemotherapeutic effectiveness, cisplatin administration is associated with numerous side effects. Of those, the most clinically significant and common effect is nephrotoxicity. Recent studies reported that oxidative stress and inflammation are probably the most important mechanisms that contribute to the nephrotoxicity. N-acetylcysteine (NAC) is an antioxidant and antiinflammatory agent. In the present study, the effects of NAC on cisplatin-induced nephrotoxicity were investigated. ⋯ It is suggested that inflammation has a limited effect on cisplatin nephrotoxicity in this experimental design, and, as reflected by decreased BUN and creatinine levels, NAC can be used as an additional therapeutic agent in standard cisplatin treatment protocols.